Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q1)Jun 30, 2020 | (FY)Mar 31, 2020 | (Q1)Jun 30, 2019 | (FY)Mar 31, 2019 | |
|---|---|---|---|---|---|---|
| Total revenue | 58.51%1.71T | 1.08T | 24.88%267.46B | -8.12%987.23B | 214.18B | 1.07T |
| Cost of revenue | -5.71%1.14T | 1.21T | -20.03%216.41B | 11.74%986.56B | 270.61B | 882.93B |
| Gross profit | 540.25%569.43B | -129.34B | 190.46%51.05B | -99.65%670M | -56.43B | 191.54B |
| Operating expense | -4.60%117.69B | 123.36B | -14.36%36.36B | 19.29%173.75B | 42.45B | 145.65B |
| Selling and administrative expenses | -0.72%127.85B | --128.77B | -11.31%36.8B | 20.90%174.03B | --41.49B | --143.95B |
| -General and administrative expense | -0.72%127.85B | --128.77B | -11.31%36.8B | 20.90%174.03B | --41.49B | --143.95B |
| Other operating expenses | -68.37%4.51B | --14.26B | -48.14%711M | -9.01%5.11B | --1.37B | --5.61B |
| Total other operating income | -25.42%14.68B | --19.68B | 182.35%1.15B | 37.73%5.39B | --408M | --3.91B |
| Operating profit | 278.77%451.75B | -252.7B | 114.86%14.69B | -477.21%-173.08B | -98.88B | 45.89B |
| Net non-operating interest income (expenses) | 10.20%-81.62B | -90.89B | 61.48%-11.91B | -55.81%-65.91B | -30.91B | -42.3B |
| Non-operating interest income | 100.70%3.71B | --1.85B | -82.66%640M | -60.07%3.48B | --3.69B | --8.72B |
| Non-operating interest expense | -7.99%85.33B | --92.74B | -63.74%12.55B | 36.01%69.39B | --34.61B | --51.02B |
| Net investment income | ||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||
| Income from associates and other participating interests | 107.66%542M | 261M | -96.57%6M | -50.81%212M | 175M | 431M |
| Special income (charges) | ||||||
| Other non-operating income (expenses) | ||||||
| Income before tax | 207.96%370.67B | -343.33B | 102.15%2.79B | -6,045.64%-238.78B | -129.62B | 4.02B |
| Income tax | 198.73%98.35B | -99.61B | 103.17%1.09B | -827.79%-72.79B | -34.43B | -7.85B |
| Net income | 211.73%272.32B | -243.72B | 101.78%1.7B | -1,499.48%-165.99B | -95.19B | 11.86B |
| Net income continuous operations | 211.73%272.32B | ---243.72B | 101.78%1.7B | -1,499.48%-165.99B | ---95.19B | --11.86B |
| Noncontrolling interests | -14.29%6M | 7M | -105.08%-3M | 170.04%694M | 59M | 257M |
| Net income attributable to the company | 211.73%272.32B | -243.73B | 101.78%1.7B | -1,536.45%-166.69B | -95.25B | 11.6B |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 211.73%272.32B | -243.73B | 101.78%1.7B | -1,536.45%-166.69B | -95.25B | 11.6B |
| Gross dividend payment | ||||||
| Basic earnings per share | 210.40%519.96 | -470.97 | 101.78%3.152 | -1,536.45%-309.215 | -176.685 | 21.5263 |
| Diluted earnings per share | 209.44%515.45 | -470.97 | 101.78%3.152 | -1,536.45%-309.215 | -176.685 | 21.5263 |
| Dividend per share | ||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |